 |
1 Disease |  |
2 Trials |
|
2 Trials |  |
38 News |  |
- | Enrollment change, HEOR: Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue (clinicaltrials.gov) - Nov 29, 2023
P2/3, N=13, Terminated, Sponsor: PhytoHealth Corporation
N=210 --> 13
- | Enrollment closed, Trial completion date, Trial primary completion date, Metastases: PH-CP028: PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer (clinicaltrials.gov) - Nov 29, 2023
P2, N=48, Active, not recruiting, Sponsor: PhytoHealth Corporation
N=210 --> 13 Recruiting --> Active, not recruiting | Trial completion date: Dec 2025 --> Feb 2025 | Trial primary completion date: May 2023 --> Feb 2023
- Effect of astragalus polysaccharides (PG2) treatment of adjuvant chemotherapy-induced fatigue in premenopausal patients with breast cancer. (Available On Demand; Poster Bd # 367) - Apr 26, 2023 - Abstract #ASCO2023ASCO_925;
P2
PG2 assists these patients with maintaining normal daily life and job activities, also less need of family support during chemotherapy. Furthermore, patients treated with PG2 might have better compliance to complete the whole course of adjuvant chemotherapy.
- || New P2 trial, Metastases: PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients (clinicaltrials.gov) - Jun 30, 2022
P2, N=36, Recruiting, Sponsor: PhytoHealth Corporation
- ||| Trial completion, Compliance: PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy (clinicaltrials.gov) - Jun 13, 2022
P2, N=67, Completed, Sponsor: PhytoHealth Corporation
Furthermore, patients treated with PG2 might have better compliance to complete the whole course of adjuvant chemotherapy. Recruiting --> Completed
- | Trial completion date, Trial primary completion date, Metastases: PH-CP028: PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer (clinicaltrials.gov) - Jun 13, 2022
P2, N=40, Recruiting, Sponsor: PhytoHealth Corporation
Recruiting --> Completed Trial completion date: Dec 2021 --> Dec 2025 | Trial primary completion date: Oct 2021 --> May 2023
- || Trial completion date, Trial primary completion date, Compliance: PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy (clinicaltrials.gov) - Apr 22, 2021
P2, N=75, Recruiting, Sponsor: PhytoHealth Corporation
Trial completion date: Dec 2021 --> Dec 2025 | Trial primary completion date: Oct 2021 --> May 2023 Trial completion date: Jun 2021 --> Oct 2021 | Trial primary completion date: Dec 2020 --> Jun 2021
- | Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date, Surgery: Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer (clinicaltrials.gov) - Apr 2, 2021
P2, N=0, Withdrawn, Sponsor: PhytoHealth Corporation
Trial completion date: Jun 2021 --> Oct 2021 | Trial primary completion date: Dec 2020 --> Jun 2021 N=50 --> 0 | Trial completion date: Mar 2022 --> Dec 2020 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2022 --> Dec 2020
- | Trial completion date, Trial primary completion date, Metastases: PH-CP028: PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer (clinicaltrials.gov) - Sep 28, 2020
P2, N=40, Recruiting, Sponsor: PhytoHealth Corporation
N=50 --> 0 | Trial completion date: Mar 2022 --> Dec 2020 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2022 --> Dec 2020 Trial completion date: Jun 2020 --> Dec 2021 | Trial primary completion date: Jun 2020 --> Oct 2021
- | Trial completion date, Trial primary completion date, Surgery: Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer (clinicaltrials.gov) - Mar 4, 2020
P2, N=50, Not yet recruiting, Sponsor: PhytoHealth Corporation
Trial completion date: Jun 2020 --> Dec 2021 | Trial primary completion date: Jun 2020 --> Oct 2021 Trial completion date: Jan 2021 --> Mar 2022 | Trial primary completion date: Jan 2021 --> Mar 2022
- || Trial completion date, Trial primary completion date, Compliance: PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy (clinicaltrials.gov) - Mar 4, 2020
P2, N=75, Recruiting, Sponsor: PhytoHealth Corporation
Trial completion date: Jan 2021 --> Mar 2022 | Trial primary completion date: Jan 2021 --> Mar 2022 Trial completion date: Aug 2020 --> Jun 2021 | Trial primary completion date: Apr 2020 --> Dec 2020
- | Trial completion date, Trial primary completion date, Surgery: Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer (clinicaltrials.gov) - Aug 28, 2019
P2, N=50, Not yet recruiting, Sponsor: PhytoHealth Corporation
Trial completion date: Aug 2020 --> Jun 2021 | Trial primary completion date: Apr 2020 --> Dec 2020 Trial completion date: Jul 2020 --> Jan 2021 | Trial primary completion date: Jul 2020 --> Jan 2021
- | Enrollment open, Trial completion date, Trial primary completion date, Metastases: PH-CP028: PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer (clinicaltrials.gov) - Aug 28, 2019
P2, N=40, Recruiting, Sponsor: PhytoHealth Corporation
Trial completion date: Jul 2020 --> Jan 2021 | Trial primary completion date: Jul 2020 --> Jan 2021 Not yet recruiting --> Recruiting | Trial completion date: Jan 2020 --> Jun 2020 | Trial primary completion date: Jan 2020 --> Jun 2020
- | Trial completion date, Trial primary completion date, Compliance: PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy (clinicaltrials.gov) - Aug 8, 2019
P2, N=75, Recruiting, Sponsor: PhytoHealth Corporation
Not yet recruiting --> Recruiting | Trial completion date: Jan 2020 --> Jun 2020 | Trial primary completion date: Jan 2020 --> Jun 2020 Trial completion date: Apr 2019 --> Aug 2020 | Trial primary completion date: Apr 2019 --> Apr 2020
- | Trial completion date, Trial primary completion date, Surgery: Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer (clinicaltrials.gov) - Sep 10, 2018
P2, N=50, Not yet recruiting, Sponsor: PhytoHealth Corporation
Trial completion date: Apr 2019 --> Aug 2020 | Trial primary completion date: Apr 2019 --> Apr 2020 Trial completion date: Jul 2019 --> Jul 2020 | Trial primary completion date: Jul 2019 --> Jul 2020
- || New P2 trial, Metastases: PH-CP028: PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer (clinicaltrials.gov) - Aug 1, 2018
P2, N=40, Not yet recruiting, Sponsor: PhytoHealth Corporation
- ||| Enrollment open, Trial initiation date, Compliance: PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy (clinicaltrials.gov) - Apr 30, 2018
P2, N=75, Recruiting, Sponsor: PhytoHealth Corporation
Trial completion date: Jul 2019 --> Jul 2020 | Trial primary completion date: Jul 2019 --> Jul 2020 Not yet recruiting --> Recruiting | Initiation date: Nov 2017 --> Mar 2018
- ||||| New P2 trial, Compliance: PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy (clinicaltrials.gov) - Oct 19, 2017
P2, N=75, Not yet recruiting, Sponsor: PhytoHealth Corporation
- |||| Trial completion, Metastases: PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care (clinicaltrials.gov) - Aug 3, 2017
P4, N=323, Completed, Sponsor: PhytoHealth Corporation
Not yet recruiting --> Recruiting | Initiation date: Nov 2017 --> Mar 2018 Recruiting --> Completed
- ||| Enrollment change, Trial primary completion date, Metastases: PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care (clinicaltrials.gov) - May 10, 2017
P4, N=350, Recruiting, Sponsor: PhytoHealth Corporation
Recruiting --> Completed N=250 --> 350 | Trial primary completion date: Jan 2017 --> Jun 2017
- | Trial initiation date, Trial primary completion date, Surgery: Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer (clinicaltrials.gov) - Sep 28, 2016
P2, N=50, Not yet recruiting, Sponsor: PhytoHealth Corporation
N=250 --> 350 | Trial primary completion date: Jan 2017 --> Jun 2017 Initiation date: Jul 2016 --> Jul 2018 | Trial primary completion date: Jul 2018 --> Jul 2019
- | Trial termination, Trial primary completion date, HEOR: Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue (clinicaltrials.gov) - Nov 10, 2015
P2/3, N=210, Terminated, Sponsor: PhytoHealth Corporation
Initiation date: Jul 2016 --> Jul 2018 | Trial primary completion date: Jul 2018 --> Jul 2019 Recruiting --> Terminated | Trial primary completion date: Jun 2010 --> Jun 2008; Sponsor's decision
- || Trial primary completion date, Metastases: PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care (clinicaltrials.gov) - Nov 10, 2015
P4, N=250, Recruiting, Sponsor: PhytoHealth Corporation
Recruiting --> Terminated | Trial primary completion date: Jun 2010 --> Jun 2008; Sponsor's decision Trial primary completion date: Dec 2015 --> Jan 2017
- Enrollment change, Trial termination, Trial primary completion date, Metastases: A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy (clinicaltrials.gov) - Nov 10, 2015
P2, N=17, Terminated, Sponsor: PhytoHealth Corporation
Trial primary completion date: Dec 2015 --> Jan 2017 N=60 --> 17 | Recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Apr 2014; Change study drug dosage form
- | Trial initiation date, Trial primary completion date, Surgery: Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer (clinicaltrials.gov) - Nov 5, 2015
P2, N=50, Not yet recruiting, Sponsor: PhytoHealth Corporation
N=60 --> 17 | Recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Apr 2014; Change study drug dosage form Initiation date: Jan 2015 --> Jul 2016 | Trial primary completion date: Dec 2015 --> Jul 2018
- || Trial primary completion date, Metastases: A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy (clinicaltrials.gov) - Apr 29, 2015
P2, N=60, Recruiting, Sponsor: PhytoHealth Corporation
Initiation date: Jan 2015 --> Jul 2016 | Trial primary completion date: Dec 2015 --> Jul 2018 Trial primary completion date: Oct 2014 --> Dec 2015
- || Trial primary completion date, Metastases: PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care (clinicaltrials.gov) - Apr 29, 2015
P4, N=250, Recruiting, Sponsor: PhytoHealth Corporation
Trial primary completion date: Oct 2014 --> Dec 2015 Trial primary completion date: Apr 2014 --> Dec 2015
- | Trial initiation date, Trial primary completion date, Surgery: Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer (clinicaltrials.gov) - Nov 5, 2014
P2, N=50, Not yet recruiting, Sponsor: PhytoHealth Corporation
Trial primary completion date: Apr 2014 --> Dec 2015 Initiation date: Mar 2014 --> Jan 2015 | Trial primary completion date: Feb 2015 --> Dec 2015
- | New P2 trial, Surgery: Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer (clinicaltrials.gov) - Mar 2, 2014
P2, N=50, Not yet recruiting, Sponsor: PhytoHealth Corporation
- ||| Trial completion: The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke (clinicaltrials.gov) - Feb 26, 2014
P0, N=60, Completed, Sponsor: PhytoHealth Corporation
Initiation date: Mar 2014 --> Jan 2015 | Trial primary completion date: Feb 2015 --> Dec 2015 Recruiting --> Completed
- |||| Enrollment open, Metastases: A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy (clinicaltrials.gov) - Apr 17, 2013
P2, N=60, Recruiting, Sponsor: PhytoHealth Corporation
Recruiting --> Completed Not yet recruiting --> Recruiting
- |||| Enrollment open, Metastases: PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care (clinicaltrials.gov) - Apr 17, 2013
P4, N=250, Recruiting, Sponsor: PhytoHealth Corporation
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| New P4 trial, Metastases: PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care (clinicaltrials.gov) - Oct 31, 2012
P4, N=250, Recruiting, Sponsor: PhytoHealth Corporation
- ||||| New P2 trial, Metastases: A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy (clinicaltrials.gov) - Oct 31, 2012
P2, N=60, Recruiting, Sponsor: PhytoHealth Corporation
- | New P1/2 trial, Metastases: PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy (clinicaltrials.gov) - Sep 27, 2012
P1/2, N=32, Completed, Sponsor: PhytoHealth Corporation
- | Trial completion: Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients (clinicaltrials.gov) - May 9, 2012
P2, N=14, Completed, Sponsor: PhytoHealth Corporation
Not yet recruiting --> Recruiting Recruiting --> Completed